Notice of Final Results and Investor Presentation

Summary by AI BETAClose X

Gelion plc will publish its audited final results for the year ended 30 June 2026 on Wednesday, 21 October 2026, followed by an investor presentation on Thursday, 22 October 2026, hosted by the CEO, CFO, and CTO. The company is developing Nano-Encapsulated Sulfur (NES™) technology as a low-cost alternative to critical minerals in lithium-ion battery cathodes, aiming for deployment within existing manufacturing lines. Investors can register for the presentation and submit questions in advance.

Disclaimer*

Gelion PLC
12 October 2026
 

A blue and white logo

AI-generated content may be incorrect.
12 October 2026

 

Gelion plc
("Gelion", the "Company" or the "Group")

 

Notice of Final Results and Investor Presentation

 

Gelion is seeking to replace the critical minerals in current lithium-ion battery cathodes with its Nano-Encapsulated Sulfur (NES™), a low-cost cathode active material made from abundantly available sulfur, that can be deployed within existing global manufacturing lines.

 

Gelion plc (LSE: GELN), the sulfur battery technology company, announces that the Company will publish audited final results for the year ended 30 June 2026 on Wednesday, 21 October 2026. An investor presentation will follow at 0900h BST on Thursday, 22 October 2026 on the Investor Meet Company platform, hosted by Matt Wood, CEO, Amit Gupta, CFO and Louis Adriaenssens, CTO. The presentation is open to all existing and prospective shareholders.

 

Registration: https://www.investormeetcompany.com/gelion-plc/register-investor

 

Questions may be submitted in advance through the Investor Meet Company dashboard up to 0800h BST on the day of the presentation, or at any time during the live event. Investors who already follow Gelion on the platform will be automatically invited.

 

For more information, please visit Next-Generation Sulfur Battery Technologies | Gelion or contact:

 

Gelion plc
Matt Wood, CEO
Amit Gupta, CFO

 

via Tavistock

Strand Hanson Limited (Nominated and Financial Adviser)
Christopher Raggett / Rob Patrick / Harry Marshall

+44 (0) 20 7409 3494

Oberon Capital (Joint Broker)
Nick Lovering / Mike Seabrook / Adam Pollock

 

+44 (0) 20 3179 5300

Allenby Capital Limited (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

 

+44 (0) 20 3328 5656

Tavistock (Financial & Corporate PR)
Simon Hudson / Nick Elwes / Saskia Sizen

+44 20 7920 3150
gelion@tavistock.co.uk

 

Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

About Gelion

Gelion plc (AIM: GELN) is an advanced battery materials company developing next-generation cathode technologies for lithium-ion and lithium-sulfur batteries. Its proprietary Nano-Encapsulated Sulfur (NES™) cathode active material is designed to replace conventional critical-mineral cathodes with abundant sulfur, delivering higher energy density while remaining compatible with existing battery manufacturing infrastructure.

 

The Company's strategy is to commercialise NES™ through partnerships with leading industrial companies and battery manufacturers, enabling adoption within established global supply chains across automotive, defence, device and other high-performance applications. Gelion works with Tier One industrial partners including TDK and Mitsui Kinzoku (Japan), QinetiQ and Nissan UK (UK), National Laboratory of the Rockies (NLR) (US), a top 15 global auto OEM, and Max Planck Institute of Colloids and Interfaces (MPI) (Germany).

 

-ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Gelion (GELN)
UK 100

Latest directors dealings